These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

943 related items for PubMed ID: 31553802

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I, Turner S, Ramakrishnan S, Fries A, Gowell M, Yasmin F, Richardson R, Webb P, O'Boyle E, Hinks TS.
    Cochrane Database Syst Rev; 2021 May 04; 5(5):CD013518. PubMed ID: 33945639
    [Abstract] [Full Text] [Related]

  • 8. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
    Cates CJ, Wieland LS, Oleszczuk M, Kew KM.
    Cochrane Database Syst Rev; 2014 Feb 06; 2014(2):CD010314. PubMed ID: 24504983
    [Abstract] [Full Text] [Related]

  • 9. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ, Karner C.
    Cochrane Database Syst Rev; 2013 Apr 30; 2013(4):CD007313. PubMed ID: 23633340
    [Abstract] [Full Text] [Related]

  • 10. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ, Lasserson TJ, Jaeschke R.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD006922. PubMed ID: 19588410
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    Cates CJ, Lasserson TJ.
    Sao Paulo Med J; 2010 Jul 08; 128(5):310-1. PubMed ID: 21181075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
    Chauhan BF, Jeyaraman MM, Singh Mann A, Lys J, Abou-Setta AM, Zarychanski R, Ducharme FM.
    Cochrane Database Syst Rev; 2017 Mar 16; 3(3):CD010347. PubMed ID: 28301050
    [Abstract] [Full Text] [Related]

  • 20. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ, Lasserson TJ.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007695. PubMed ID: 19821436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.